Ultomiris (ravulizumab)

pCPA File Number: 21780

Negotiation Status:

Under consideration for negotiation

Indication(s):

Paroxysmal nocturnal hemoglobinuria (PNH)

Sponsor/Manufacturer:

Alexion Pharma Canada Corp.

CADTH Project Number:

SR0700

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable